Postoperative Pain Relief

Published on 17/04/2015 by admin

Filed under Surgery

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1779 times

Chapter 7 Postoperative Pain Relief

Introduction and background

The goal of postoperative pain relief is to achieve optimal analgesia, facilitating a quick return to normal activities with minimal side effects. In addition, the effective treatment of acute postoperative pain may reduce the incidence of chronic pain after surgery. Acute postoperative pain differs from chronic or cancer pain because it is more transitory and there may be an affective component relating to anxiety about the outcome of the surgical procedure and concern for suboptimal analgesia. Studies have shown that for patients awaiting surgery the possibility of severe acute postoperative pain is a major concern.1 In addition, uncontrolled postoperative pain can lead to delayed recovery from surgery, pulmonary dysfunction and hypoxia, together with restriction of mobility and subsequent increased risk of thromboembolism. Surveys in the UK, the USA and Europe have identified an unacceptable prevalence of poor pain control after surgery.2,3 However, in recent years the introduction of acute pain management services in hospitals has promoted improvements in postoperative pain.4 In addition, the use of ‘multimodal’ or ‘balanced’ analgesia – a combination of opiates, non-steroidal antiinflammatory drugs (NSAIDs), local anaesthetics and other adjuvants have been recommended to manage postoperative pain. Recently, White and Power reviewed the evidence for such pain management. They showed that multimodal analgesia improves the efficacy of pain relief, decreases the risk of side effects and is an evidence-based, established effective strategy for postoperative pain management.5,6

Measurement of pain

In adults, three common methods of self-reported pain measurement are used.

Each of these methods of measurement is reasonably reliable as long as the endpoints and adjectives employed are carefully selected and standardized.

Available methods of pain relief

Paracetamol

Paracetamol (acetaminophen) is an acetanilide derivative with the molecular formula C8H9NO2. It is one of the most commonly used drugs worldwide, owing in part to its excellent safety record. Paracetamol has analgesic and antipyretic but not antiinflammatory activity. It is believed to be a centrally acting cyclooxygenase (COX) inhibitor with weak peripheral effects. Current evidence points to multi-site activity in the central nervous system, involving inhibition of prostaglandin synthesis and interaction with both serotonergic and cannabinoid pathways. Paracetamol can be given orally and rectally. An intravenous formulation is now available and has become widely used in the UK as it provides rapid and predictable therapeutic plasma concentrations. Rectal administration is restricted by slow onset time and unpredictable bioavailability and is becoming less popular.

Adverse effects/complications

Cox-2 inhibitors

In an effort to minimize the potential for bleeding at the surgical site and to reduce the incidence of serious gastrointestinal adverse effects and renal dysfunction associated with traditional NSAIDs, selective COX-2 inhibitors, also named ‘coxibs’, such as rofecoxib and celecoxib, were developed . Other novel COX-2 inhibitors with improved biochemical selectivity recently developed include etoricoxib, valdecoxib, parecoxib and lumiracoxib. These ‘coxibs’ have similar analgesic efficacy to that of NSAIDs, with reduced risk of bleeding and less gastrointestinal toxicity. However, large outcome and epidemiological studies suggest that while COX-2 inhibitors do confer improved gastrointestinal safety, they are not devoid of gastrointestinal effects during long-term use. Two of these drugs have already been withdrawn because of safety concerns: rofecoxib because of cardiovascular problems and valdecoxib because of serious subcutaneous adverse reactions.12

Concerns have also been raised regarding the increased incidence of thrombotic complications (leading to myocardial infarction and stroke) associated with selective COX-2 compounds.13 COX-2 inhibition with coxibs may increase the risk of vascular thrombus formation by upsetting the balance between pro- and anti-platelet aggregation effects: thromboxane A2 synthesis is primarily a COX-1-induced effect, and prostaglandin I2 synthesis a COX-2 effect.

Opiates

Opioid drugs are effective postoperative analgesics and are the principal drugs used to combat moderate to severe pain. The most commonly used drugs are morphine, codeine, oxycodone and tramadol. Pethidine is no longer recommended for postoperative analgesia because repeat doses may lead to accumulation of its metabolite, norpethidine, which can lead to confusion and seizures. It also has a very high incidence of nausea and vomiting. Opioids can be given orally, intravenously, subcutaneously, transdermally, intra-articularly, transmucosally and by the intramuscular (i.m.) route. They can also be administered by anaesthetists through the spinal or epidural route. Oral dosing of opioids is usually the most convenient and least expensive route of administration; it is appropriate as soon as the patient can tolerate oral intake and is the mainstay of pain management in the ambulatory surgical population. Intravenous PCA, in which the patient has control over the timing of each dose, has become the standard method of providing postoperative analgesia after major surgery.

Opioid receptors

Opioids produce their effect by binding to opioid receptors located in the brain and spinal cord. A number of different opioid receptor types have been identified: mu (µ), delta (δ), kappa (κ) and sigma (σ). There are two subtypes of µ receptors – µ1 and µ2 – with subtype µ1 mediating analgesia and µ2 responsible for respiratory depression. All currently available µ receptor agonist opioids activate both subtypes.

Summary Box 7.3 Side effects of opioids

Respiratory Respiratory depression
Central nervous system Sedation, euphoria
  Nausea and vomiting
Cardiovascular Vasodilation, bradycardia
  Myocardial depression
Genitourinary Urinary retention
Gastrointestinal Delayed gastric emptying
  Constipation
  Pruritus

Side effects (complications) of opioid drugs

All of the opioid drugs that we commonly use for pain management in the postoperative setting act primarily at the µ receptor sites and all have a fairly similar spectrum of side effects. In equianalgesic doses and in most patients, the incidence of side effects is generally very similar regardless of the opioid used (Table 7.1).

Table 7.1 Side effects of opioid drugs

1. Respiratory Respiratory depression
2. Central nervous system Sedation, euphoria (or dysphoria)
  Nausea, vomiting, miosis, muscle rigidity
3. Cardiovascular Vasodilatation, bradycardia, myocardial depression
4. Pruritus Common with morphine
5. Genitourinary Urinary retention
6. Gastrointestinal Delayed gastric emptying constipation
7. Allergy Allergic reactions to opioid drugs are very uncommon

The most important side effects of opioids are respiratory depression, which may be severe and result in hypoxia. Sedation is routinely monitored postoperatively using a sedation score and, while respiratory rate is also monitored, it is routine practice to use continuous pulse oximetry in all postoperative patients in the recovery room or postanaesthetic care unit (PACU). Opioids are implicated as one of the risk factors in postoperative nausea and vomiting (PONV) and are assigned 1 point in the Apfel risk scoring system.16 In all cases where opioids are used intraoperatively or postoperatively, antiemetics should be given as prophylaxis. Combination antiemetic prophylaxis with drugs having different mechanisms of action have been shown in many studies to markedly reduce the incidence of PONV. Ondansetron and cyclizine have been shown to achieve a response rate of 95%.17

Patient-controlled analgesia

PCA using opioids (usually morphine) has become the standard of care at many hospitals, for the management of postoperative pain. The term ‘PCA’ is used to describe a method of analgesia which employs sophisticated infusion devices which allow patients to self-administer opioids, usually intravenously. Most PCA systems incorporate microprocessor-driven syringe pumps that, within preset limits, will deliver a bolus dose of morphine when the patient presses a demand button connected to the pump. Access to the syringe and the microprocessor program are only possible using a key or an access code. Certain variables are prescribed and programmed into the PCA pump which control how much opioid the patient can receive. Most machines can also deliver a continuous or ‘background’ infusion. Patients using PCA are instructed to push the demand button whenever they are uncomfortable. Where the patient is unable to use either hand, other mechanisms have been devised to enable the patient to use the machine in a ‘demand’ mode (pneumatic device, pressure-sensitive pad, etc.). The inherent safety of the PCA technique lies in the fact that as long as the machine is in PCA mode only (i.e. there is no continuous infusion) no further doses of opioid will be delivered should the patient become sedated, because no further demands will be made.

Oral analgesics

The most commonly used drugs for mild to moderate pain in the postoperative period are codeine, or codeine plus paracetamol combinations. Oxycodone and tramadol are also increasingly used.

Local anaesthetic techniques

Peripheral nerve blocks

The use of single-shot or continuous peripheral nerve blocks is becoming increasingly popular for postoperative analgesia following major upper limb surgery. Peripheral nerve blocks provide excellent analgesia with minimal motor blockade. This facilitates early and more effective joint mobilization and physiotherapy, while limiting reflex muscle spasm. They also avoid the side effects of PCA morphine (sedation, PONV). In addition, with the increased use of day case facilities and minimally invasive surgery, e.g. arthroscopic elbow surgery, more procedures are being carried out under regional anaesthesia as a sole technique.

Ultrasound-guided regional nerve block

The use of ultrasound guidance has become increasingly popular in regional anaesthesia over the past few years. The advantages of ultrasound guidance include the real-time visualization of anatomical structures and the spread of anaesthetic.24 Peripheral nerve stimulation relies on placing the needle close to the target nerve, but cannot make allowances for individual anatomical variation or reliably predict the spread of the local anaesthetic. Using high-resolution real-time ultrasound visualization during peripheral nerve block may further increase success rates, decrease latency of the block, reduce the volume of local anaesthetic used, shorten time to perform the blocks and has the potential to reduce or eliminate the risk of accidental intravascular or intraneural injection. A number of recent studies support these claims.

A study by Chan et al, reporting a retrospective analysis of 662 axillary blocks, found that in the ultrasound-guided group the block success rate was higher compared to the traditional group (91.6% versus 81.9%). The US-guided axillary block group also required a lower volume of local anaesthetic and had a shorter time in the block room.25 Combined ultrasound and nerve stimulation guided techniques are now being used more frequently with high success rates. Finally, National Institute for Health and Clinical Excellence (NICE) guidelines (January 2009) also supported the increased efficacy and safety profile of ultrasound-guided nerve blocks.26

Current practice in our institution

References

1 Van den Bosch JE, Bonsel GJ, Moons KG, et al. Effect of postoperative experiences on willingness to pay to avoid postoperative pain, nausea, and vomiting. Anaesthesiology. 2006;104:1033-1039.

2 Bruster S, Jarman B, Bosanquet N, et al. National survey of hospital patients. BMJ. 1994;309:1542-1546.

3 Apfelbaum JL, Chen C, Mehta S, et al. Postoperative pain experience: results from a national survey suggest postoperative pain continues to be under-managed. Anesth Analg. 2003;97:534-540.

4 Werner MU, Soholm L, Rotboll-Nielsen P, et al. Does an acute pain service improve postoperative outcome? Anesth Analg. 2002;95:1361-1372.

5 White PF. The changing role of non-opioid analgesic techniques in the management of postoperative pain. Anesth Analg. 2005;101:S5-22.

6 Power I. Recent advances in postoperative pain therapy. Br J anaesth. 2005;95:43-51.

7 Hyllested M, Jones S, Pedersen JL, et al. Comparative effect of paracetamol, NSAIDS or their combination in postoperative pain management: a qualitative review. Br J Anaesth. 2002;88:199-214.

8 Gregoire N, Hovsepian L, Gualano V, et al. Safety and pharmacokinetics of paracetamol following intravenous administration of 5 g during the first 24 h with a 2 g starting dose. Clin Pharmacol Ther. 2007;81:401-405.

9 Marret E, Kurdi O, Zufferey P, et al. Effects of nonsteroidal anti-inflammatory drugs on patient-controlled analgesia morphine side effects: meta-analysis of randomised controlled trials. Anesthesiology. 2005;102:1249-1260.

10 Marret E, Flahaut A, Samama C-M, et al. Effects of postoperative nonsteroidal anti-inflammatory drugs on bleeding risk after tonsillectomy. Anaesthesiology. 2003;98:1497-1502.

11 Dsida R, Cote C. Nonsteroidal anti-inflammatory drugs and hemorrhage following tonsillectomy: do we have the data? Anaesthesiology. 2004;100:749-751.

12 Nussmier NA, Whelton AA, Brown MT, et al. Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med. 2005;352:1081-1091.

13 Kearney PM, Baigent C, Godwin J, et al. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ. 2006;332:1302-1303.

14 Comfort VK, Code WE, Rooney ME, et al. Naproxen premedication reduces postoperative tubal ligation pain. Can J Anaesth. 1992;39:349-352.

15 O’Hanlon JJ, Muldoon T, Lowry D, et al. Improved postoperative analgesia with preoperative piroxicam. Can J Anaesth. 1996;43:102-105.

16 Apfel CC, Roewer N, Kortila K. How to study postoperative nausea and vomiting. Acta Anaesth Scand. 2002;46:921-928.

17 Ahmed AB, Hobbs GJ, Curran JP. Randomized, placebo-controlled trial of combination antiemetic prophylaxis for day-case gynaecological laparoscopic surgery. Br J Anaesth. 2000;85:678-682.

18 Cochrane for Clinicians. Patient-controlled analgesia for postoperative pain. Am Fam Physician. 2007;76(11):1645.

19 de Beer JdeV, Winemaker MJ, Donnely GA, et al. Efficacy and safety of controlled-release oxycodone and standard therapies for postoperative pain after knee or hip replacement. Can J Surg. 2005;48:277-283.

20 Beaulieu P. Non-opioid strategies for acute pain management. Can J Anesth. 2007;54:481-485.

21 Beaudet V, Williams SR, Tetreault P, et al. Perioperative interscalene block versus intra-articular injection of local anesthetics for postoperative analgesia in shoulder surgery. Reg Anaesth Pain Med. 2008;33(2):134-139.

22 Borgeat A, Schapp B, Biasca N, et al. Patient controlled analgesia after major shoulder surgery: patient controlled interscalene analgesia versus patient controlled analgesia. Anaesthesiology. 1997;87:1343-1347.

23 Rawal N, Axelsson K, Hylander J, et al. Postoperative patient-controlled local anesthetic administration at home. Anesth Analg. 1998;86:86-89.

24 Marhofer P, Greher M, Kapral S. Ultrasound guidance in regional anaesthesia. Br J Anaesth. 2005;94:7-17.

25 Lo N, Brull R, Perlas A, et al. Evolution of ultrasound guided axillary brachial plexus blockade: retrospective analysis of 662 blocks. Can J Anesth. 2008;55:408-413.

26 Ultrasound-guided regional nerve block. Interventional procedure guidance 285. National Institute for Health and Clinical Excellence, Ref No. N1779; January 2009.